In a separate report released by the medical journal, Dr. Eric Topol of the Cleveland Clinic chastises the FDA for requiring Merck to do studies investigating heart problems with Vioxx when hints of them appeared years, and for allowing the company to blitz consumers with TV ads touting the drug.
Ramsey Co. Last week, Gilmartin and Kim said that none of the earlier Vioxx studies, by either the company or others, showed increased heart and stroke risk from the drug.
